| HOME >> MEDICINE >> TECHNOLOGY |
Carlsbad, Calif., Aug. 7, 2013 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the PowerViral™ Environmental RNA/DNA Isolation Kit, for isolation of viral and bacterial nucleic acids from challenging samples such as stool, waste water, biosolids and gut material.
(Photo: http://photos.prnewswire.com/prnh/20130807/LA58944)
The PowerViral™ Environmental RNA/DNA Isolation Kit is the latest product in MO BIO's Power line of kits which contain patented Inhibitor Removal Technology® (IRT). IRT eliminates inhibitory substances often contained in stool and waste water, such as undigested plant material in the gut or heme compounds from lysed red blood cells, abundant in stool, resulting in pure nucleic acids that are ready to use in PCR, cDNA synthesis, RT-qPCR and more.
Features of the PowerViral™ Environmental RNA/DNA Isolation Kit include:
- Optimized for challenging samples – Isolate viral and bacterial RNA & DNA from waste water, stool, biosolids and gut material
- Inhibitor Removal Technology® – Eliminates inhibitory substances, including polysaccharides, lipids and heme for pure nucleic acids that are ready to use in downstream applications
- Optional bead beating protocol– Available with Glass Bead Tubes for optimal lysis of solid samples and bacterial cells or without bead tubes for isolation of viral nucleic acids from liquid samples
The PowerViral™ Environmental RNA/DNA Isolation Kit is available now. For more information, visit the MO BIO website (http://www.mobio.com/pages/powerviral.html) or call 800-606-6246.
MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in molecular biology since 1993. A global leader in solutions for soil and microbial nucleic acid purification, MO BIO's Power kits contain patented Inhibitor Removal Technology® for removal of PCR inhibiting substances during the nucleic acid purification procedure. For clinical samples, the BiOstic™ kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.
'/>"/>
| SOURCE MO BIO Laboratories, Inc. Copyright©2012 PR Newswire. All rights reserved |
Related medicine technology :
1. Global Vascular Stents Market 2012-2016 Report with Abbott Laboratories, Medtronic Inc. and Boston Scientific Corp. Dominating
2. Charleston Laboratories, Inc. Announces Successful Completion of Pre-IND Meeting on New Migraine Treatment CL-H1T
3. Clontech Laboratories, Inc. Partners With Rubicon Genomics To Increase Speed And Efficiency Of Sample Preparation For RNA Sequencing
4. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
5. FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
6. Antigen Laboratories, Inc. to be Acquired by Ares Life Sciences
7. Positive Data, Pipeline Improvements & Market Expansion - Research Report on Abbott Laboratories, Stryker Corporation, St. Jude Medical, Cardiovascular Systems and MAKO Surgical
8. Charleston Laboratories, Inc. Begins Enrollment for CL-108 Phase 3 Clinical Trial
9. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
10. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
11. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |